Search results
Found 16154 matches for
Wearable devices offer exciting opportunities to longitudinally detect and track multi-modal stress and symptoms of disease in an objective and unobtrusive way.
SINAPPS2 Background & PPiP2 Recruitment Training Confirmation
The SINAPPS2 Trial is inviting people with acute psychosis symptom(s) and anti-neuronal membrane antibodies who have been identified through PPiP2 study to consent the trial and help testing the efficacy and safety of immunotherapy for antibody-associated psychosis.